Jeff Nau, PhD, president and CEO of Oyster Point Pharma shares an update on the company's Tyrvaya product.
Jeff Nau, PhD
Advertisement
Articles by Jeff Nau, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Jeff Nau, PhD, president and CEO of Oyster Point Pharma shares an update on the company's Tyrvaya product.
.png "Optometry Times"){kind=logo}
